Clinical Report: Delirium and Adverse Effects Associated with Misuse of Compound Liquorice Tablets
Overview
This case study highlights a 29-year-old male who developed severe delirium and multiple complications after escalating misuse of compound liquorice tablets.
Background
Compound liquorice tablets, containing opium powder and liquorice, have gained popularity as an easily accessible alternative for cough treatment, particularly during the COVID-19 pandemic. However, the addiction potential and severe adverse effects of this medication are often overlooked in clinical practice.
Data Highlights
No numerical data or trial data was presented in the article.
Key Findings
The patient developed delirium characterized by confusion, disorientation, and hallucinations after discontinuing compound liquorice tablets.
Withdrawal symptoms included palpitations, hypertension, tremors, and severe hypokalemia.
The patient was diagnosed with opioid-induced mental and behavioral disorders according to ICD-10 criteria.
Comprehensive management included benzodiazepines, antidepressants, and antipsychotics, leading to resolution of symptoms.
This case is the first reported instance of delirium linked to withdrawal from compound liquorice tablets.
Clinical Implications
Healthcare professionals should be aware of the potential for addiction and withdrawal symptoms associated with compound liquorice tablets.
Conclusion
This case report serves as a reminder of the risks associated with compound liquorice tablets.
